Conference:
Pre-conference workshop
1 Dec 9am - 5pm
Day 1
2 Dec 8.30am - 5:30pm
Day 2
3 Dec 8.30am - 5:30pm
Post-conference workshop
4 Dec 8.30am - 5:30pm
Venue:
The Bloomsbury Hotel, London, United Kingdom
› Email a friend
› Add this to my calendar
|
|
|
Meet our speakers
Dr Mohanish Anand, Head of Clinical Research, Pfizer, Inc., United Kingdom Director, Late Phase Solutions, Medidata, United States of America Vice President, Global Medical Affairs, Epidemiology and Outcomes Research, Quintiles, Netherlands Director, Global Outcome Surveys, Shire HGT, Sweden UK LSD Registry Co-ordinator, Genzyme Therapeutics, United Kingdom Project Director, Novo Nordisk, Denmark Former Head of Department, IQWiG, Germany Associate Medical Director, Wyeth Pharma, Germany Associate Director, IIIb/IV Trials, Pfizer, Inc., United Kingdom Medical Science Director, AstraZeneca Pharmaceuticals (Pty ) Ltd South Africa, South Africa Vice President, Peri-Approval Clinical Excellence, Americas, Clinical Research Services, Parexel International, United States of America Director, Clinical Development, GlaxoSmithKline, Belgium Director, Clinical Development and Medical Affairs, Pfizer, Inc., United Kingdom Clinical Operations Manager, Global Medical Science & Communication, Actelion, Switzerland Dr Rudi Scheerlinck, Director Global Medical Safety & Risk Management, UCB Pharma S.A., Belgium Associate Group Director - Post Marketing, Genentech, Inc, United States Vice President, i3 Innovus Late Phase International, Chief Medical Officer, GlaxoSmithKline, Belgium Therapy Lead, Oncology, Eli Lilly, China Executive Vice President, Phase IV Development, Pharmanet Pte Ltd, Singapore Director, Medical Programmes, Amylin Pharmaceuticals, Inc, United States |
|
|
|
Dr Ellen Strahlman
Chief Medical Officer
GlaxoSmithKline
Dr Clive Morris
Medical Science Director
AstraZeneca
Mark Latymer
Scientific Advisor
Pfizer
Amy Sing
Associate Group Director - Post Marketing
Genentech
Professor Markus Kosch
Associate Medical Director
Wyeth Pharma
|
|
|
|
